Chu Yu Waye Insider Trades

Insider Trading History

Track insider trading activity for Chu Yu Waye. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Medical Officer
Holding Value $597k 189,446 shares
Last Trade
Mar 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$116k 21,279 shares
$5.45
$3.15
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Medical Officer
Holding Value $945k 300,000 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.83M 300,000 shares
$6.09
$3.15
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Medical Officer
Holding Value $664k 210,725 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$457k 75,000 shares
$6.09
$3.15
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Medical Officer
Holding Value $276k 87,500 shares
Last Trade
Sep 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$254k 87,500 shares
$2.90
$3.15
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Medical Officer
Holding Value $428k 135,725 shares
Last Trade
Mar 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.42k 4,025 shares
$0.60
$3.15
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Medical Officer
Holding Value $750k 238,000 shares
Last Trade
Feb 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$304k 353,000 shares
$0.86
$3.15
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Medical Officer
Holding Value $386k 122,500 shares
Last Trade
Jan 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$206k 122,500 shares
$1.68
$3.15
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Medical Officer
Holding Value $1.18M 375,000 shares
Last Trade
Jul 19, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$683k 375,000 shares
$1.82
$3.15
Fate Therapeutics
Fate Therapeutics FATE
Chief Medical Officer
Holding Value $309k 142,993 shares
Last Trade
Apr 18, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.6k 2,532 shares
$6.57
$2.16
Fate Therapeutics
Fate Therapeutics FATE
Chief Medical Officer
Holding Value $918k 425,000 shares
Last Trade
Feb 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.88M 425,000 shares
$6.77
$2.16
Fate Therapeutics
Fate Therapeutics FATE
Chief Medical Officer
Holding Value $309k 143,208 shares
Last Trade
Jan 10, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$41k 7,825 shares
$5.24
$2.16
Fate Therapeutics
Fate Therapeutics FATE
Chief Medical Officer
Holding Value $326k 151,033 shares
Last Trade
Apr 19, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$144k 4,062 shares
$35.37
$2.16
Fate Therapeutics
Fate Therapeutics FATE
Chief Medical Officer
Holding Value $115k 53,058 shares
Last Trade
Jan 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.12M 53,058 shares
$39.87
$2.16
Fate Therapeutics
Fate Therapeutics FATE
Chief Medical Officer
Holding Value $335k 155,095 shares
Last Trade
Jan 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.33M 33,302 shares
$39.87
$2.16
Fate Therapeutics
Fate Therapeutics FATE
Senior VP Clinical Development
Holding Value $263k 121,793 shares
Last Trade
Jan 11, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$20.5k 418 shares
$49.10
$2.16
Fate Therapeutics
Fate Therapeutics FATE
Senior VP Clinical Development
Holding Value $264k 122,211 shares
Last Trade
Jan 11, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$172k 3,547 shares
$48.44
$2.16
Fate Therapeutics
Fate Therapeutics FATE
Senior VP Clinical Development
Holding Value $281k 130,261 shares
Last Trade
Dec 10, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$45.4k 900 shares
$50.42
$2.16
Fate Therapeutics
Fate Therapeutics FATE
Senior VP Clinical Development
Holding Value $288k 133,258 shares
Last Trade
Dec 10, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$369k 7,500 shares
$49.16
$2.16
Fate Therapeutics
Fate Therapeutics FATE
Senior VP Clinical Development
Holding Value $227k 105,000 shares
Last Trade
Dec 10, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$369k 7,500 shares
$49.16
$2.16
Fate Therapeutics
Fate Therapeutics FATE
Senior VP Clinical Development
Holding Value $272k 125,758 shares
Last Trade
Dec 10, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$246 5 shares
$49.16
$2.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up